J. De Bie

BCR-ABL1 positive B-ALL can undergo T-cell lineage shift to become CD19 negative T-ALL

S. Demeyer, L. Michaux, J. Cools, 2018, HemaSphere.

Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping

J. Vermeesch, S. Demeyer, L. Michaux, 2022, American journal of hematology.

The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia

S. Demeyer, K. Jacobs, J. Cools, 2020, Clinical Cancer Research.

Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors.

S. Demeyer, E. Radaelli, J. Cools, 2016, Blood.

Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia

Ira W. Deveson, W. Tam, R. Dickins, 2021, Nature Communications.

Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia

T. Voet, S. Demeyer, L. Michaux, 2018, Leukemia.

The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia

Jonathan L. Schmid-Burgk, E. Vanstreels, V. Hornung, 2016, Clinical Cancer Research.

Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia

S. Demeyer, J. Meijerink, E. Radaelli, 2018, Cancer cell.